MLEC — Moolec Science Sa Income Statement
0.000.00%
- $24.38m
- $44.54m
- $5.63m
Annual income statement for Moolec Science Sa, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.905 | 5.63 |
Cost of Revenue | |||||
Gross Profit | — | — | — | -0.143 | 0.473 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.321 | 1.6 | 4.51 | 11.1 | 14.7 |
Operating Profit | -0.321 | -1.6 | -4.51 | -10.2 | -9.04 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.321 | -1.99 | -4.53 | -52 | -8.36 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.321 | -1.99 | -4.53 | -51.8 | -7.31 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.321 | -1.99 | -4.53 | -51.8 | -7.31 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.321 | -1.99 | -4.53 | -51.8 | -7.31 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -0.053 | -0.098 | -1.44 | -0.193 |
Dividends per Share |